Rezultati

eNauka >  Rezultati >  Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2).
Naziv: Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2).
Autori: Goel, Shom; O'Shaughnessy, Joyce; Tan, Antoinette R; Milev-Krastev, Boris; Rugo, Hope S; Aftimos, Philippe Georges; Yardley, Denise A; Andric, Zoran G  ; Wolfgang, Curt Douglas; Sorrentino, Jessica;
Tao, Wenli; Beelen, Andrew Paul; Malik, Rajesh K; Jain, Sarika;
Godina: 2021
Publikacija: JOURNAL OF CLINICAL ONCOLOGY
ISSN: 0732-183X Journal of Clinical Oncology Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 39 br. 15 str. TPS1107-TPS1107
DOI: 10.1200/JCO.2021.39.15_suppl.TPS1107
WoS-ID: 000708120306161
URI: https://enauka.gov.rs/handle/123456789/823243
Projekat: G1 Therapeutics, Inc
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

1
OpenCitations
2
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.